Driven by the need for a better way to prioritize targets for drug development, the Icahn School of Medicine at Mount Sinai has led the development of a novel “genetic priority score” (GPS) that will integrate various types of human genetic data into a single easy-to-interpret score.
Still No Easy Way to Take RA Patients Off Anti-TNF Drugs
Rheumatoid arthritis (RA) patients in remission who had tumor necrosis factor (TNF) inhibitors withdrawn stepwise still faced markedly increased risk of disease flares compared with